Tag: ELIMINATE-AF
First patient enrolled in Daiichi Sankyo’s ELIMINATE-AF edoxaban study
The first patient has been enrolled into Daiichi Sankyo’s ELIMINATE-AF study. The multinational, randomised phase 3b study will explore the safety and efficacy of...